Clinical Trial Update: A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating palbociclib with fulvestrant or tamoxifen in metastatic breast cancer (hormone receptor positive) has completed recruitment with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Palbociclib (palbociclib)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of California, San Francisco | Conditions: Metastatic Breast Cancer, Hormone Receptor Positive | Phase 2 | Status: COMPLETED | Results posted: 2022-03-16